Revolutionary kidney transplant trial aims to free patients from daily medications
NCT ID NCT04540380
ACTIVE_NOT_RECRUITING
⭐️ CURE ⭐️
Sponsor: Massachusetts General Hospital
Source: ClinicalTrials.gov ↗
Summary
This study tests a new treatment approach for kidney transplant patients. It aims to safely train the patient's immune system to accept the donor kidney without needing lifelong anti-rejection drugs. The trial involves 20 adults receiving their first living-donor kidney transplant, using a special conditioning regimen before and after surgery.
Study contact
Locations
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States